Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: From the looks of things

From the looks of things

posted on Mar 29, 2006 02:08PM
we may not see an 8-k or a new deal before the dividend date. Not sure if there`s logical reasoning behind that possibility. It`s not like were changing qtrs.
Share
New Message
Please login to post a reply